Amgen reports its earnings rose by 50 percent

Amgen trounced Wall Street expectations with a 50 percent jump in its third-quarter profit to $1.86 billion, due to lower expenses and higher sales for nearly all the biologic drugmaker’s ’medicines.

A day after receiving an impressive fourth drug approval in the past year, the maker of injected osteoporosis treatment Prolia on Wednesday raised its 2015 profit forecast and issued an even higher one for 2016.